Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Without competition, drug prices soar

By , Globe Staff

Harvard-affiliated doctors said speeding up the rollout of lower-priced generics would help tamp down rising drug prices.

Foreign investors eye local lab sites

By , Globe Staff

With rental demand strong from the life sciences sector, overseas buyers target biomedical research properties.

CRISPR takes the wraps off joint venture with Bayer

By , Globe Staff

The two drug makers are set to announce that they are forming a joint venture to develop drugs based on CRISPR’s gene-editing technology.

Dispatches from life sciences’ blogger-in-chief

By , Globe Staff

If you want to track the movement of Travis McCready, president of the Massachusetts Life Sciences Center, as well as his musings on the history and potential of the critical sector, check out his newly launched “Blog of Life Sciences Discourses.”